[Characteristics of biochemical disorders in hereditary enzymopathies in humans and animals].
D000818:Animals; D004195:Disease Models, Animal; D004789:Enzyme Activation; D004791:Enzyme Inhibitors / Q000378:metabolism; D005733:Gangliosidoses / Q000201:enzymology; D005776:Gaucher Disease / Q000201:enzymology; D005952:Glucose-6-Phosphatase / Q000378:metabolism; D005959:Glucosidases / Q000172:deficiency; D006008:Glycogen Storage Disease / Q000201:enzymology; D006801:Humans; D008661:Metabolism, Inborn Errors / Q000201:enzymology*; D051379:Mice; D008816:Mice, Jimpy; D008957:Models, Genetic; D009083:Mucopolysaccharidoses / Q000201:enzymology; D009542:Niemann-Pick Diseases / Q000201:enzymology; D010764:Phosphorylase Kinase / Q000172:deficiency; D011755:Pyrophosphatases / Q000172:deficiency; D051381:Rats; D013108:Sphingomyelin Phosphodiesterase / Q000172:deficiency
D004791:Enzyme Inhibitors; D010764:Phosphorylase Kinase; D005952:Glucose-6-Phosphatase; D013108:Sphingomyelin Phosphodiesterase; D005959:Glucosidases; D011755:Pyrophosphatases
Osobennosti biokhimicheskikh narusheniĭ pri nasledstvennykh énzimopatiiakh u cheloveka i zhivotnykh.